Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy.
Saved in:
| Title: | Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy. |
|---|---|
| Authors: | Campone, M.1,2, Bondarenko, I.3, Brincat, S.4, Hotko, Y.5, Munster, P. N.6, Chmielowska, E.7, Fumoleau, P.8, Ward, R.9, Bardy-Bouxin, N.10, Leip, E.11, Turnbull, K.11, Zacharchuk, C.11, Epstein, R. J.12 |
| Source: | Annals of Oncology. Mar2012, Vol. 23 Issue 3, p610-617. 8p. 1 Diagram, 3 Charts, 4 Graphs. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 72441294 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Campone%2C+M%2E%22">Campone, M.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Bondarenko%2C+I%2E%22">Bondarenko, I.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Brincat%2C+S%2E%22">Brincat, S.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Hotko%2C+Y%2E%22">Hotko, Y.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Munster%2C+P%2E+N%2E%22">Munster, P. N.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Chmielowska%2C+E%2E%22">Chmielowska, E.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Fumoleau%2C+P%2E%22">Fumoleau, P.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Ward%2C+R%2E%22">Ward, R.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Bardy-Bouxin%2C+N%2E%22">Bardy-Bouxin, N.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Leip%2C+E%2E%22">Leip, E.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Turnbull%2C+K%2E%22">Turnbull, K.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Zacharchuk%2C+C%2E%22">Zacharchuk, C.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Epstein%2C+R%2E+J%2E%22">Epstein, R. J.</searchLink><relatesTo>12</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Mar2012, Vol. 23 Issue 3, p610-617. 8p. 1 Diagram, 3 Charts, 4 Graphs. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=72441294 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdr261 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 610 Titles: – TitleFull: Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Campone, M. – PersonEntity: Name: NameFull: Bondarenko, I. – PersonEntity: Name: NameFull: Brincat, S. – PersonEntity: Name: NameFull: Hotko, Y. – PersonEntity: Name: NameFull: Munster, P. N. – PersonEntity: Name: NameFull: Chmielowska, E. – PersonEntity: Name: NameFull: Fumoleau, P. – PersonEntity: Name: NameFull: Ward, R. – PersonEntity: Name: NameFull: Bardy-Bouxin, N. – PersonEntity: Name: NameFull: Leip, E. – PersonEntity: Name: NameFull: Turnbull, K. – PersonEntity: Name: NameFull: Zacharchuk, C. – PersonEntity: Name: NameFull: Epstein, R. J. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2012 Type: published Y: 2012 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 23 – Type: issue Value: 3 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |